TARRYTOWN, N.Y., Nov. 21, 2016 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announcedthat Leonard Schleifer, M.D., Ph.D., Founder, President and Chief Executive Officer, and George Yancopoulos, M.D., Ph.D., Founding Scientist, President of Regeneron Laboratories and Chief
The EY Entrepreneur Of The Year Award, a leading business award for entrepreneurs, recognizes leaders and visionaries who demonstrate innovation, financial success and personal commitment as they create and build world-class businesses. A panel of independent judges selected Drs. Schleifer and Yancopoulos from more than 250 regional award recipients.
"Under Len and George's leadership, Regeneron has grown from a tiny start-up into a leading biotechnology company," said P. Roy Vagelos, M.D., Chairman of the Regeneron Board of Directors. "Even now, as the company has grown to over 5,000 employees, Len and George continue to lead with a fierce entrepreneurial spirit and a willingness to do things differently. This spirit has enabled the Regeneron team to bring important medicines to people in need and to advance a promising pipeline of therapies for serious diseases."
To view the full list of this year's winners, please visit: http://www.ey.com/us/en/about-us/entrepreneurship/entrepreneur-of-the-year.
About Regeneron Pharmaceuticals, Inc.Regeneron (NASDAQ: REGN) is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for eye diseases, high LDL cholesterol and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including rheumatoid arthritis, atopic dermatitis, asthma, pain, cancer and infectious diseases. For additional information about the company, please visit www.regeneron.com or follow @Regeneron on Twitter.
About EY Entrepreneur Of The Year™The EY Entrepreneur Of The Year is the world's most prestigious business award for entrepreneurs. The program makes a difference through the way it encourages entrepreneurial activity among those with potential and recognizes the contribution of people who inspire others with their vision, leadership and achievement. As the first and only truly global awards program of its kind, Entrepreneur Of The Year celebrates those who are building and leading successful, growing and dynamic businesses, recognizing them through regional, national and global awards programs in more than 145 cities in more than 60 countries. ey.com/eoy
About EYEY is a global leader in assurance, tax, transaction and advisory services. The insights and quality services we deliver help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities.
EY refers to the global organization and may refer to one or more of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. For more information about our organization, please visit ey.com.
Media Contact at Regeneron:Alexandra Bowie, Tel. [email protected]
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/regeneron-ceo-leonard-schleifer-and-cso-george-yancopoulos-named-ey-2016-national-life-sciences-entrepreneurs-of-the-year-300366403.html
SOURCE Regeneron Pharmaceuticals, Inc.
Subscribe to our Free Newsletters!
Snake antivenom is a medicine used for the treatment of patients suffering from snake envenomation.
Breast Cancer Risk Assessment Calculator predicts the risk for breast cancer. Find list of breast ...
Ovarian cancer refers to cancer of ovaries. It is called the "Silent killer", as it is difficult to ...View All